Parallel Session 3409

Understanding and Managing Psychiatric Complications in Parkinson's Disease

Tuesday, October 6, 2026
14:30 - 16:00 | Conference Room E5, Level 3

In this session, the faculty will discuss our growing understanding of phenomenology and pathophysiology of neuropsychiatric issues which have enormous impact in the clinical management of Parkinson's disease, focusing on anxiety, impulse control disorders, apathy and psychosis.

Chairs:

Simon Lewis, Australia
Francesca Morgante, United Kingdom

Presenters:

The Many Faces of Anxiety in Parkinson's Disease
Lucia Ricciardi, United Kingdom

Impulse Control Disorders and Apathy
Campbell Le Heron, New Zealand

Understanding the Spectrum of Psychosis in Parkinson's Disease
Jaime Kulisevsky, Spain

CSPC Liaison(s):

Laura Silveira-Moriyama, Brazil

Learning Objectives

At the conclusion of this session, participants should be better able to:

1. Understand the variable pathophysiology and clinical manifestations of anxiety in Parkinson's disease
2. Understand how different brain areas and networks contribute to impulse control disorders and apathy in Parkinson's disease and how to approach these issues in clinical practice
3. Understand the manifestations and mechanisms of delirium, hallucinations and paranoia in Parkinson's disease

Recommended Audience

Clinician / General Neurology
Fellow / Resident / Student
Health Professional (non-physician)
Industry
Researcher / Basic Science

Education Level

Advanced / Expert
Beginner / Foundational
Intermediate / Experienced